HUP0304042A2 - Cefemszármazékok és ezeket tartalmazó gyógyászati készítmények, valamint eljárás a vegyületek előállítására - Google Patents

Cefemszármazékok és ezeket tartalmazó gyógyászati készítmények, valamint eljárás a vegyületek előállítására Download PDF

Info

Publication number
HUP0304042A2
HUP0304042A2 HU0304042A HUP0304042A HUP0304042A2 HU P0304042 A2 HUP0304042 A2 HU P0304042A2 HU 0304042 A HU0304042 A HU 0304042A HU P0304042 A HUP0304042 A HU P0304042A HU P0304042 A2 HUP0304042 A2 HU P0304042A2
Authority
HU
Hungary
Prior art keywords
amino
lower alkyl
vacuo
mixture
solution
Prior art date
Application number
HU0304042A
Other languages
English (en)
Hungarian (hu)
Inventor
Hisashi Akamatsu
Satoshi Inoue
Kenji Itoh
Kohji Kawabata
Keiji Misumi
Takashi Ogino
Hidenori Ohki
Shinya Okuda
Kenji Satoh
Toshio Yamanaka
Original Assignee
Fujisawa Pharmaceutical Co., Ltd.
Wakunaga Pharmaceutical Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPR4690A external-priority patent/AUPR469001A0/en
Priority claimed from AUPR5834A external-priority patent/AUPR583401A0/en
Application filed by Fujisawa Pharmaceutical Co., Ltd., Wakunaga Pharmaceutical Co., Ltd. filed Critical Fujisawa Pharmaceutical Co., Ltd.
Publication of HUP0304042A2 publication Critical patent/HUP0304042A2/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
HU0304042A 2001-05-01 2002-04-24 Cefemszármazékok és ezeket tartalmazó gyógyászati készítmények, valamint eljárás a vegyületek előállítására HUP0304042A2 (hu)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPR4690A AUPR469001A0 (en) 2001-05-01 2001-05-01 Cephem compounds
AUPR5834A AUPR583401A0 (en) 2001-06-20 2001-06-20 Cephem compounds
PCT/JP2002/004058 WO2002090364A1 (en) 2001-05-01 2002-04-24 Cephem compounds

Publications (1)

Publication Number Publication Date
HUP0304042A2 true HUP0304042A2 (hu) 2004-04-28

Family

ID=25646666

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0304042A HUP0304042A2 (hu) 2001-05-01 2002-04-24 Cefemszármazékok és ezeket tartalmazó gyógyászati készítmények, valamint eljárás a vegyületek előállítására

Country Status (19)

Country Link
US (1) US7179801B2 (enExample)
EP (1) EP1392704B1 (enExample)
JP (1) JP4251873B2 (enExample)
KR (1) KR20030090794A (enExample)
CN (1) CN1522259A (enExample)
AR (1) AR033300A1 (enExample)
AT (1) ATE318269T1 (enExample)
BR (1) BR0209452A (enExample)
CA (1) CA2446099A1 (enExample)
DE (1) DE60209341T2 (enExample)
ES (1) ES2254671T3 (enExample)
HU (1) HUP0304042A2 (enExample)
MX (1) MXPA03010002A (enExample)
NO (1) NO20034824L (enExample)
NZ (1) NZ529887A (enExample)
PL (1) PL366507A1 (enExample)
RU (1) RU2003134629A (enExample)
TW (1) TWI224599B (enExample)
WO (1) WO2002090364A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4448821B2 (ja) * 2002-10-30 2010-04-14 アステラス製薬株式会社 セフェム化合物
AU2003902380A0 (en) * 2003-05-16 2003-06-05 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
DE602004026451D1 (de) * 2003-09-18 2010-05-20 Astellas Pharma Inc Cephem-verbindungen
WO2005044819A1 (en) * 2003-10-28 2005-05-19 Schering Corporation Process for preparing substituted 5-amino-pyrazolo-[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines
EP1721906A4 (en) * 2004-03-05 2008-02-27 Shionogi & Co METHYLCEPHEM COMPOUND 3-PYRIDINIUM
JP2009530228A (ja) * 2006-03-16 2009-08-27 アステラス製薬株式会社 セフェム化合物および抗菌薬としての利用
HK1200096A1 (en) 2011-09-09 2015-07-31 Merck Sharp & Dohme Corp. Methods for treating intrapulmonary infections
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
US20140274994A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Stabilizing ceftolozane
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
US20140274993A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Ceftolozane-tazobactam pharmaceutical compositions
US10376496B2 (en) 2013-09-09 2019-08-13 Merck, Sharp & Dohme Corp. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US8906898B1 (en) 2013-09-27 2014-12-09 Calixa Therapeutics, Inc. Solid forms of ceftolozane
CN104140427A (zh) * 2014-07-05 2014-11-12 湖南华腾制药有限公司 一种四氢吡唑并[1,5-a]嘧啶的制备方法
CN107922435B (zh) * 2015-09-08 2022-05-17 桑多斯股份公司 由7-氨基头孢烷酸(7-aca)制备头孢洛扎的方法
CN107586305A (zh) * 2017-06-23 2018-01-16 浙江惠迪森药业有限公司 一种β‑内酰胺类化合物羧基及羟基保护基脱除方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5194432A (en) * 1985-11-22 1993-03-16 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
CA1293719C (en) * 1986-09-22 1991-12-31 Takao Takaya Cephem compounds and processes for preparation thereof
US5210080A (en) * 1987-09-07 1993-05-11 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
US5663163A (en) * 1987-09-07 1997-09-02 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds and processes for preparation thereof
IE63094B1 (en) * 1987-09-14 1995-03-22 Fujisawa Pharmaceutical Co Cephem compound and a process for preparation thereof
US5173485A (en) * 1988-03-09 1992-12-22 Fujisawa Pharmaceutical Company, Ltd. Cephem compounds
GB8905301D0 (en) * 1989-03-08 1989-04-19 Fujisawa Pharmaceutical Co New cephem compound and a process for preparation thereof
US5215982A (en) * 1989-11-10 1993-06-01 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
KR910015587A (ko) * 1990-02-27 1991-09-30 후지사와 토모키치로 세펨 화합물
JPH09110877A (ja) 1995-10-17 1997-04-28 Katayama Seiyakushiyo:Kk セフェム化合物、その製造法及びそれを含有する抗菌剤
AUPN955596A0 (en) * 1996-04-30 1996-05-23 Fujisawa Pharmaceutical Co., Ltd. New compound
JP4448821B2 (ja) * 2002-10-30 2010-04-14 アステラス製薬株式会社 セフェム化合物
AU2003902380A0 (en) * 2003-05-16 2003-06-05 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
DE602004026451D1 (de) * 2003-09-18 2010-05-20 Astellas Pharma Inc Cephem-verbindungen

Also Published As

Publication number Publication date
AR033300A1 (es) 2003-12-10
NZ529887A (en) 2005-05-27
JP2004529172A (ja) 2004-09-24
ES2254671T3 (es) 2006-06-16
CN1522259A (zh) 2004-08-18
CA2446099A1 (en) 2002-11-14
NO20034824D0 (no) 2003-10-29
KR20030090794A (ko) 2003-11-28
WO2002090364A1 (en) 2002-11-14
TWI224599B (en) 2004-12-01
ATE318269T1 (de) 2006-03-15
EP1392704A1 (en) 2004-03-03
JP4251873B2 (ja) 2009-04-08
DE60209341T2 (de) 2006-08-03
RU2003134629A (ru) 2005-06-10
US7179801B2 (en) 2007-02-20
PL366507A1 (en) 2005-02-07
MXPA03010002A (es) 2004-06-30
NO20034824L (no) 2003-12-29
DE60209341D1 (de) 2006-04-27
EP1392704B1 (en) 2006-02-22
US20040248875A1 (en) 2004-12-09
BR0209452A (pt) 2004-12-14

Similar Documents

Publication Publication Date Title
KR101023035B1 (ko) 세펨 화합물
US4952578A (en) Cephem compound and a process for preparation thereof
HUP0304042A2 (hu) Cefemszármazékok és ezeket tartalmazó gyógyászati készítmények, valamint eljárás a vegyületek előállítására
US20090012054A1 (en) Cephem Compounds and Use as Antimicrobial Agents
JP4643577B2 (ja) セフェム化合物
EP0261615A2 (en) Cephem compounds, processes for preparation thereof and pharmaceutical compositions comprising them
FI93732C (fi) Menetelmä valmistaa farmakologisesti arvokasta kefeemiyhdistettä
WO1992021683A1 (en) New cephem compounds
US20050004094A1 (en) Cephem compounds
EP0237735A2 (en) 3,7-Disubstituted-3-cephem compounds and process for production of the same
HUT72737A (en) New cephem compounds
AU2002253562A1 (en) Cephem compounds
JPH05222058A (ja) 新規セフェム化合物およびその塩
JPH06135972A (ja) 新規セフェム化合物
JPH0426692A (ja) 新規セフェム化合物
AU2005202802A1 (en) Cephem compounds
HU205939B (en) Process for producing new cephalosporing derivatives and pharmaceutical compositions containing them
HUT69683A (en) New cephem compounds of antimicrobial activity

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees